跳至主要内容
临床试验/NCT05462249
NCT05462249终止不适用

Impact of Catch-up HPV Vaccination on the Development of Cervical Lesions

University Hospital, Brest1 个研究点 分布在 1 个国家目标入组 354 人开始时间: 2021年5月21日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
354
试验地点
1
主要终点
Test HPV and smear test result.

研究概览

简要总结

Each year in France, more than 6000 new cases of HPV inducted cancers are recorded. The vaccinal cover stays insufficient since less than 30% of the french population is vaccinated. Therefore french studies about vaccine efficacy and especially about the catch-up vaccine (done after 15years old) are needed.

HPVAC2 is a prospective, analytic and monocentric study designed to learn the impact of the catch-up HPV vaccination.

Women from 25 years old and born after 1984 may be included if they come to the Brest CHU to do their regular cervical smear. At this time, a survey will be given to know their vaccinal status.

The aim of the study is to prove the efficacy of the catch up vaccination by analyzing the cervical smears results and by comparing the vaccinated group with the not-vaccinated group.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
25 Years 至 38 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Age limit
  • Patient must have done a HPV or smear test during the study period
  • Consent necessary

排除标准

  • Age limit
  • No HPV or smear test done in the study period
  • Patient not able to give her consent

结局指标

主要结局

Test HPV and smear test result.

时间窗: 13 months.

Study the effectiveness of anti-HPV vaccine (done between 15 and 19 years old).

次要结局

  • Test HPV and smear test result.(13 months.)
  • Test HPV and smear test result regarding the cervical cancer risk factors.(13 months.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验